Cardiac Biotech Solutions, Inc. (CBSC)
0.0345
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
Cardiac Biotech Solutions Enterprise Value : 6.406M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 6.406M |
| November 18, 2026 | 6.406M |
| November 17, 2026 | 6.406M |
| November 16, 2026 | 6.406M |
| November 13, 2026 | 6.406M |
| November 12, 2026 | 6.406M |
| November 11, 2026 | 6.406M |
| November 10, 2026 | 6.406M |
| November 09, 2026 | 6.406M |
| November 06, 2026 | 6.406M |
| November 05, 2026 | 6.406M |
| November 04, 2026 | 6.406M |
| November 03, 2026 | 6.406M |
| November 02, 2026 | 6.406M |
| October 30, 2026 | 5.724M |
| October 29, 2026 | 5.690M |
| October 28, 2026 | 5.690M |
| October 27, 2026 | 5.690M |
| October 26, 2026 | 5.690M |
| October 23, 2026 | 6.099M |
| October 22, 2026 | 6.099M |
| October 21, 2026 | 6.099M |
| October 20, 2026 | 6.099M |
| October 19, 2026 | 6.579M |
| October 16, 2026 | 6.579M |
| Date | Value |
|---|---|
| October 15, 2026 | 6.579M |
| October 14, 2026 | 6.579M |
| October 13, 2026 | 6.579M |
| October 12, 2026 | 6.491M |
| October 09, 2026 | 6.491M |
| October 08, 2026 | 6.491M |
| October 07, 2026 | 6.491M |
| October 06, 2026 | 6.491M |
| October 05, 2026 | 6.491M |
| October 02, 2026 | 6.491M |
| October 01, 2026 | 6.491M |
| September 30, 2026 | 6.491M |
| September 29, 2026 | 5.886M |
| September 28, 2026 | 5.886M |
| September 25, 2026 | 5.886M |
| September 24, 2026 | 5.886M |
| September 23, 2026 | 5.886M |
| September 22, 2026 | 6.729M |
| September 21, 2026 | 6.729M |
| September 18, 2026 | 6.729M |
| September 17, 2026 | 6.729M |
| September 16, 2026 | 6.729M |
| September 15, 2026 | 6.729M |
| September 14, 2026 | 6.576M |
| September 11, 2026 | 6.576M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vyome Holdings, Inc. | 4.791M |
| Abbott Laboratories | 207.35B |
| AngioDynamics, Inc. | 433.25M |
| Alphatec Holdings, Inc. | 1.596B |
| AtriCure, Inc. | 2.665B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1372M |
| Revenue (Quarterly) | 0.0402M |
| Total Expenses (Quarterly) | 0.1773M |
| EPS Diluted (Quarterly) | -0.0008 |
| Profit Margin (Quarterly) | -341.3% |
| Earnings Yield | -14.78% |
| Normalized Earnings Yield | -20.00 |